Group items tagged

Overview: In this session we will discuss the HIPAA audit and enforcement programs and how they work, and discuss the areas that caused the most issues in prior audits. We will explore what kind of issues and what kind of entities had the most problems, and show where entities need to improve their compliance the most. We will also explore the typical risk issues that lead to breaches of health information and see how those issues may be a target for auditors in the new 2016 audits. We will review the contents of the HIPAA Audit Protocol used in 2012 to show what documentation needs to be on hand should your organization be selected for an audit in the new round. We will present methods for using the contents of the HIPAA Audit Protocol to build your own compliance plan by extracting and updating the contents and relating your compliance activities directly to the questions that might be asked. In this session we will discuss the HIPAA audit and enforcement regulations and processes, and how they apply to HIPAA covered entities and business associates. We will explain the enforcement regulations and the new, increased fines and new penalty levels, including new penalties for willful neglect of compliance that begin at $10,000. We will discuss what information and documentation must be prepared in advance so that you can be ready for an audit at any time, including sample information request forms and questions asked at prior audits. The session will also cover how to know if you may become the subject of an audit or enforcement action, and what you can do to help limit your exposure. We will discuss how most enforcement actions come about and what can be done to prevent incidents that lead to enforcement activity. The HIPAA Privacy, Security, and Breach Notification regulations (and the recent changes to them) and how they will be audited will be explained. Documentation requirements for compliance will be explored and a framework of security policies necessary

Anti-counterfeit packaging solutions such as radio-frequency identification (RFID), forensic techniques, 2D barcodes, holograms, and more are used to protect customers from counterfeit products. Secure packaging plays a key role in preventing the counterfeiting of any product. Anti-counterfeiting packaging provides a secure and safe packaging solution to the product, in order to eliminate infringement and counterfeiting. Stringent laws and regulations enforced by governments are expected to drive growth of the global anti-counterfeit packaging market during the forecast period. The government of many countries has enforced stringent regulations and laws to curb the counterfeiting of products. Furthermore, in September 2020, the International Trademark Association (INTA) announced to step up its efforts to combat counterfeit products with new laws under consideration. Moreover, in December 2019, in the U.S., the SANTA Act (Stopping All Nefarious Toys in America Act) was introduced that set requirements for online marketplaces selling toys to verify seller information and disclose it to consumers. Read more @ https://sachinbhombe.blogspot.com/2021/03/anti-counterfeit-packaging-market.html

Medical sensors are becoming an integral part of medical facilities throughout the world. They enable facilities to monitor all aspects of patient care, from room temperature to vital signs, from pulse rates to oxygen levels, and more. This is a new frontier in patient care that has the potential to dramatically save money and reduce staff fatigue. A medical sensor system can include a variety of different instruments in various formats, ranging from a simple temperature probe attached to a belt clip to highly sophisticated electronic devices capable of monitoring dozens of different parameters. The most common type of medical sensor is a small portable electronic device that is affixed to a person's skin or clothes. These are designed for use in a wide variety of patient care settings including hospitals, rehabilitation centers, and home health care agencies. They are often used by cardiologists and nurses to monitor heart rates and pulse rates as well as measurements of blood pressure and respiration. Increasing demand for medical sensors is expected to propel growth of the global medical sensors market. For instance, 2020, OSI Systems, Inc. announced that its Optoelectronics division received an order to provide optical sensors for use in medical devices from a leading healthcare original equipment manufacturer. Moreover, high prevalence of chronic diseases is also expected to aid in growth of the market. Read more @ https://sachinbhombe.blogspot.com/2021/03/increasing-demand-for-medical-sensors.html

Autoclaves are also known as steam sterilizers and are used to expose each item to direct steam contact at the required temperature and pressure for the specified time. They are used for healthcare or industrial applications to eliminate the protein structure of the bacteria and spores. Compatible of steam autoclaves for crisis strategy decontamination of N95 respirators is expected to propel growth of the global steam autoclave market. For instance, in October 2020, 3M, a U.S-based multinational conglomerate corporation, announced that Belimed steam autoclaves are compatible for crisis strategy decontamination of specific single-use N95 Respirators. Moreover, launch of biological indicators for steam autoclaves is also expected to aid in growth of the market. For instance, in December 2020, Steris Corporation, a U.S-based medical equipment company, launched Spordex Self-Contained Biological Indicator Ampoules to confirm sterilization of liquids in steam autoclave cycles. Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global steam autoclave market. For instance, globally, as of 4:03pm CET, 1 March 2021, there have been 113,820,168 confirmed cases of COVID-19, including 2,527,891 deaths, reported to the World Health Organization. Moreover, high prevalence of hospital-acquired infections is also expected to aid in growth of the market. For instance, according to an observational epidemiological study of intra-abdominal infections published in December 2019, in NEJM Journal Watch, of the 2621 critically ill adults with intra-abdominal infections at 309 international centers between January and December 2016, 32% were community-acquired, while 68% were hospital-acquired. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/emergence-of-covid-19-and-lunch-of-new.html

The term "portable diagnostic device" (or PDD for short) refers to a wide range of medical devices that are either made for external use (that can be used in the field) or for internal use in the doctor's office. They are designed to be used quickly and easily by any patient and also provides continuous and non-invasive monitoring of health parameters. Moreover, they also provide real-time information to a healthcare provider through connectivity. Growing advancement in the field of medical device such as smart wearable's and image-guided therapy systems is predominantly fueling the growth of the portable diagnostic device market. For instance, in January 2019, Royal Philips announced Azurion with FlexArm, to set a new standard for patient imaging and positioning flexibility for image-guided procedures. Rising awareness regarding the advantage of portable medical devices is again anticipated to foster market growth. Increasing the manufacturer's focus on the development of compact, wireless, and user-friendly is again projected to foster the growth of the portable diagnostic device market. Growing advancement in the field of embedded systems, sensors, and electronics is contributing to market growth over the forecast period. Also, the growing geriatric population is increasing the prevalence of chronic diseases such as diabetes and cancer which is again driving demand for portable diagnostic devices. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/are-smart-wearable-and-image-guided.html

High prevalence of gastric cancer is expected to propel growth of the gastric cancer therapeutics market. For instance, according to The American Cancer Society, the U.S. is estimated to record about 26,560 cases of stomach cancer and about 11,180 people will die from this type of cancer in 2021. Moreover, R&D in oral chemotherapy for the treatment of gastric cancer is also expected to aid in growth of the market. For instance, in January 2021, Ascelia Pharma AB announced the clinical development plan for Oncoral, with which the company has the opportunity to develop a novel oral chemotherapy for the treatment of gastric cancer. Risk factors for gastric cancer may include smoking and a diet of highly processed or salty foods. Thus, high number of smokers is expected to offer lucrative growth opportunities for players in the gastric cancer therapeutics market. For instance, according to the World Health Organization's, May 2020 Update, tobacco leads to over 8 million deaths each year worldwide and over 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-gastric-cancer-and.html

Practice management system helps manage the daily operations of an organization. The system helps organization (or facility) to settle meetings with specialists, record persistent information, keep up record, create last reports, etc. A medical practice management system provides staff members with real-time visibility into each patient's availability, enabling them to quickly identify potential scheduling problems. The system send email or text message (appointment reminders) to patients, reducing the possibility of a full-blown event that could negatively impact patient flow. Practice management system find wide application across various verticals in an industry. Increasing integration of healthcare system with practice management solutions is expected to propel the growth of the practice management system market. For instance, in January 2021, Brevium, an innovative SaaS company in the healthcare sector announced that it has extended the integration of its software with one of the premier electronic practice management systems in the U.S., Nextech. Moreover, rising incentives by federal government are also expected to foster the practice management system market growth. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/rapid-growth-of-healthcare-industry-to.html

The Trump administration announced that it will withhold $200 million in federal healthcare funding (including abortion) to California.

Kidney stones, also known as renal calculi, occur when the liquid stored in the kidneys becomes too concentrated. The stone, once lodged in the urinary tract, obstructs the urine flow from it and causes great pain in the abdomen. Other symptoms of a kidney stone include a burning sensation or an intense desire to urinate frequently. Also experiencing frequent urge to pass urine. Kidney stones can be treated effectively, due to presence of advanced methods and associated medical devices. Kidney stone management devices are widely used to retrieve kidney stones. Increasing prevalence of kidney stones and the increasing preference for minimally invasive surgeries worldwide is expected to propel the growth of the kidney stone management devices market. For instance, according to the United States National Kidney Foundation, every year, more than half a million people go to emergency rooms for kidney stone problems. It is estimated that one in ten people will have a kidney stone at some time in their lives. Moreover, increasing product launches, technological advancements, and increasing research and development activities for the prevention and treatment of kidney stones is expected to augment the growth of the kidney stone management devices market. For instance, in August 2020, Dornier MedTech (Dornier) announced the launch of UroX, a community that connects professionals from various disciplines to cultivate innovation and solve the most pressing challenges in urology. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/increasing-prevalence-of-kidney-stones.html

Micro guide catheters are used in order to guide the urethra so that you can have an easy time inserting your pet's urethra and not be worried about any kind of blockage at all. There are many types of these devices available in the market. Some of these are manual tube and electric as well. Many people prefer to use micro guide catheters because they are made very simple and with great ease of use. A growing number of surgical procedures for treating cardiovascular diseases is fueling the growth of the micro guide catheters market. According to the American College of Cardiology Foundation, in 2017, emergency medical services-assessed out-of-hospital cardiac arrest occurred in an estimated 356,461 Americans; emergency medical services treatment was initiated in 52%. In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. The increasing development of modern disposable catheters that are safer and more comfortable to insert is further projected to foster the growth of the micro guide catheters market. North America is projected to gain significant growth over the forecast period and this is attributed to the continuous launch of innovative products by ley players in the region. For instance, in March 2017, Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and the U.S. commercial launch of the TrapLiner Catheter. The TrapLiner Catheter was developed by Vascular Solutions Inc., which was acquired by Teleflex. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/rise-in-number-of-cardiovascular.html

Germany's BioNTech and its US partner Pfizer announced on Friday that their coronavirus vaccine can stand warmer temperatures than what was thought initially.

The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services has announced relaxation in HIPAA rules for covered entities and business associates who participate in good faith in the COVID-19 testing site operation. It doesn't stop there, but HIPAA penalties won't apply to covered healthcare providers for practicing telehealth medicine using third-party applications such as Skype or Facebook Messenger

The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services has announced relaxation in HIPAA rules for covered entities and business associates who participate in good faith in the COVID-19 testing site operation.

Corona has overburdened the healthcare system, and CMS has announced some relaxations for eligible physicians to facilitate them. Read how CMS has eased the MIPS 2020 data submission process.

Biostimulants are natural or synthetic substances that aid in reducing the dependency on fertilizers. These substances are applied to seeds, plants, and soil in order to increase plant growth, resistance to water and abiotic stresses. Increasing global population has led to focus on boosting crop yield. According to projections by Population Reference Bureau (PRB) included in the 2018 World Population Data Sheet, the world population is expected to reach 9.9 billion by 2050, up 2.3 billion or 29% from an estimated 7.6 billion people in 2018. Moreover, according to according to Food and Agriculture Organization, worldwide food demand is expected to increase by 70% by 2050. Decrease in arable land in various regions has led to has led to various challenges in the agricultural sector. According to the study 'Will Limited Land, Water, and Energy Control Human Population Numbers in the Future', published in the journal Human Ecology, the amount of arable land available per person will decrease to 1500m² by 2050 from 4000m² in 1961. In July 2020, the government of India was expected to announce guidelines to regulate the biostimulants market in the country. Earlier, in July 2019, Europe witnessed several changes regarding definition and classification of these substances. Read More @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/increasing-global-population-and-focus.html

Advanced Therapy Medicinal Products (ATMPs) offer a real and tangible hope for many different chronic illnesses for which there currently are no or limited therapeutic options. The science and technology that support these products are developing rapidly and therefore the products that are on the market today will undoubtedly continue to improve and grow in effectiveness and capability over time. Patients around the world are now beginning to experience the benefits of these improved products. One such product is Stem Cell Therapy, which uses stem cells from healthy cells taken from the patient's own body. High prevalence of Alzheimer's disease is expected to propel growth of the advanced therapy medicinal products market. For instance, According to the data from Alzheimer's Association, around 5.7 million people in the U.S. were suffering from Alzheimer's disease in 2018. Moreover, increasing adoption of gene therapy is also expected to aid in growth of the market. For instance, in March 2020, AVROBIO, Inc., a clinical-stage gene therapy company, announced that a second patient in the AVR-RD-04 Phase 1/2 clinical trial in cystinosis has been enrolled and has completed apheresis. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/high-prevalence-of-alzheimers-disease.html

National Digital Health Mission​, this ambitious mission is a move forward in strengthening the Indian health infrastructure lacking patient records and health. The government's proposal, now put up for public review, focuses on necessary data privacy measures that need to be put in place in order to safeguard the confidentiality of sensitive health information of citizens. Announced by the Prime Minister, the mission aims to "voluntarily" give every Indian citizen a unique health ID which will serve as a digital repository containing all their health data as well as provide an ​enrolment of​ doctors and health facilities. For more details read the blog completely

The emergence of COVID-19 (the global pandemic) is driving the growth of the patient-centric healthcare app market. Telehealth has the potential to address many of the key challenges in providing health services during the outbreak of COVID-19. Moreover, the pandemic has made video telemedicine the safest interactive system between patients and clinicians. For example, in May 2021, Proximus innovated in the field of e-Health with patient-centric teleconsultation app Doktr. The company announced the launch of Doktr, an innovative video teleconsultation service allowing patients with a basic primary care need to get in touch with a qualified doctor in a convenient and secure way. A patient-centric approach is a way the healthcare systems can establish a partnership among practitioners, patients, and their families to align decisions with patients' wants, needs, and preferences. Patient centric health care app helps provide information and deliver services to patients regarding their health, thereby improving patient's health. It offers access to health information and easy connectivity between patients and doctors. Moreover, these apps help users to stay updated about medication times, number of calories consumed, dehydration level in body, etc. Therefore, there is an increasing demand for patient-centric healthcare around the world, driving the growth of the patient centric healthcare app market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/08/the-outbreak-of-covid-19-to-augment.html

The growing incidence of viral conjunctivitis cases is driving the growth of the viral conjunctivitis drugs market. According to National Center for Biotechnology: 2017, adenovirus is the most common cause of viral conjunctivitis and up to 70% of cases of acute conjunctivitis are viral. The number of individuals affected by viral conjunctivitis is estimated to be as high as 15 to 20 million per year in the U.S. Additionally, a rising number of research and development activities for enhancing the effectiveness of viral conjunctivitis drugs is again projected to accelerate the growth of the market. For instance, in 2019, iVIEW Therapeutics Inc., a clinical-stage ophthalmology drug development company, announced the dosing of the first patient in Phase II clinical trial. iVIEW Therapeutics Inc. is testing the safety and efficacy of the IVIEW-1201 in patients (age ≥15 years) for the treatment of acute adenoviral conjunctivitis. In 2018, Starpharma Holdings Limited, a company headquartered in Australia, received a patent for SPL7013 ophthalmic drops for viral conjunctivitis from the U.S. Patent and Trademark Office. The patent has been granted to the company due to its broad claims for treating and preventing microbial infections of the eye, including adenoviral conjunctivitis, bacterial conjunctivitis, and other eye infections. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/08/starpharma-holdings-limited-received.html

We are thrilled to announce that Instapay Healthcare Services is now offering specialized Chiropractic Revenue Cycle Management (RCM) and Chiropractic Billing Services across the U.S.!

Overview: The webinar will concentrate on topics that HHS has announced will be the focus of the first round of "desk audits". They reflect significant areas of non-compliance revealed in the 2012 pilot audits and HHS HIPAA violation investigations concluded by Resolution Agreements and Corrective Action Plans. They include: HIPAA Risk Analysis Risk Management based on Risk Analysis Breach Notification Notice of Privacy Practices (for Covered Entities) Minimum Necessary Standard Access of Individuals to their PHI Authorizations Workforce Training This webinar is vital because, in focusing on preparation for a HIPAA Compliance Audit, Covered Entities and Business Associates may review, prioritize and structure their HIPAA Compliance programs. If you have HIPAA Compliance documentation ready to submit on two weeks notice to HHS you are implementing an effective HIPAA Compliance program. In addition, every Covered Entity or Business Associate may face an HHS HIPAA Compliance investigation at any time due to a complaint or a Breach. If you are "audit ready" you will be ready for an investigation - and better able to avoid complaints and prevent breaches. Why should you attend: Every Covered Entity and Business Associate is liable - without prior notice - to be audited for HIPAA Compliance by HHS You will have only 2 weeks after receiving your HIPAA Compliance Audit notification and data request to upload all requested documents to an HHS HIPAA Compliance Audit Portal The HIPAA Compliance Audit data request you receive will specify content and file organization, file names and any other document submission requirements Auditors will not contact an audited entity for clarifications or ask for additional information - it is essential that submitted documents are current, accurately reflect the entity's HIPAA Compliance program and demonstrate HIPAA Compliance Only data submitted on time will be assessed Failure to respond on time may be referred to the HHS regional